IMC Chicago’s Ocugen OCGN Stock Holding History

IMC Chicago’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$110K	Buy	71,800 +4,800	+7%	+$7.3K	﹤0.01%	5949
2026 Q1	$121K	Buy	+67,000	New	+$116K	﹤0.01%	5263
2022 Q1	–	Sell	-84,100	Closed	-$383K	–	1187
2021 Q4	$383K	Buy	+84,100	New	+$635K	﹤0.01%	1129

Other funds holding OCGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

IMC Chicago's OCGN Position: Q2 2026 in Review

IMC Chicago sold out of Ocugen (OCGN) in Q2 2026, closing a stake of 11,569 shares — an estimated $17.6K sold.

IMC Chicago first reported a position in OCGN in Q1 2026 and held it in 1 quarter. The position peaked at $20.9K in Q1 2026. 147 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

IMC Chicago reported no remaining Ocugen position as of Q2 2026 after selling out during the quarter.
IMC Chicago sold 11,569 Ocugen shares in Q2 2026, an estimated $17.6K.
IMC Chicago first reported a position in Ocugen in Q1 2026 and held it in 1 quarter.
IMC Chicago's Ocugen position peaked at $20.9K in Q1 2026.
147 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.